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T regulatory (Treg) cells play a role in the suppression
of immune responses, thus serving to induce toler-
ance and control autoimmunity. Here, we explored
whether Tregcells influence the immediatehypersen-
sitivity response of mast cells (MCs). Treg cells
directly inhibited the Fc3RI-dependent MC degranu-
lation through cell-cell contact involving OX40-
OX40L interactions between Treg cells and MCs,
respectively. When activated in the presence of
Treg cells, MCs showed increased cyclic adenosine
monophosphate (cAMP) concentrations and reduced
Ca2+ influx, independently of phospholipase C (PLC)-
g2 or Ca2+ release from intracellular stores. Antago-
nism of cAMP in MCs reversed the inhibitory effects
of Treg cells, restoring normal Ca2+ responses and
degranulation. Importantly, the in vivo depletion or
inactivation of Treg cells caused enhancement of
the anaphylactic response. The demonstrated cross-
talk between Treg cells andMCs defines a previously
unrecognized mechanism controlling MC degranula-
tion. Loss of this interaction may contribute to the
severity of allergic responses.
INTRODUCTION
Allergies are increasingly prevalent in the population of western
countries (Ring et al., 2001). Allergic hypersensitivity is associ-
ated with both immunoglobulin E (IgE) and T helper 2 (Th2) cell
responses to environmental allergens. In allergic individuals,
priming of allergen-specific CD4+ Th2 cells by antigen-present-
ing cells (APCs) results in the production of Th2 cell cytokines,
which are responsible for initiating B cell production of allergen-
specific IgE. IgE binds to the high-affinity receptor for IgE(Fc3RI) on mast cells (MCs) and basophils. Allergen crosslinking
of cell-surface-bound allergen-specific IgE leads to the release
of preformed and granule-stored allergic mediators like hista-
mine, aswell as the secretion of de novo-synthesizedprostaglan-
dins, cysteinyl leukotrienes, cytokines, and chemokines. Gran-
ule-stored mediators are key to the immediate (acute) allergic
reactions, such as the wheal and flare response in the skin
(Williams and Galli, 2000), whereas de novo-synthesized media-
tors are more important in the late (chronic) phase of the allergic
response.
The homeostatic mechanisms regulating MC number and
function in peripheral tissues are largely dependent on Th2 cell
cytokines, such as interleukin-3 (IL-3), IL-4, IL-5, IL-9, and IL-13
(Shelburne and Ryan, 2001). Some of these cytokines are key in
enhancingMCsurvival (IL-3) or recruitment (IL-9) to effector sites,
but in general, Th2 cell cytokines establish a positive feedback
loop that maintains the Th2 cell response (Lorentz et al., 2005).
Environmental factors, such as exposure to allergens, infections,
and air pollution, interact with genetic factors to influence the
progression of the immune response toward a Th2 cell pheno-
type, resulting in allergen-specific IgE production and subse-
quent allergen-mediated activation of MCs promoting allergic
disease (Umetsu et al., 2002). However, the immunological
mechanisms that control in vivo Th2 cell-driven inflammation or
that dampen MC-mediated allergic response are not fully
understood.
Regulatory T cells are crucial in preventing the development of
autoimmune diseases,maintaining self-tolerance, and regulating
the development and the intensity of the immune response to
foreign antigens, including allergens (Lohr et al., 2006). In recent
years, the naturally occurring CD4+CD25+Foxp3+ regulatory T
(Treg) cells and an inducible population of allergen-specific
IL-10-secreting type 1 Treg (Tr1) cells have been implicated in
promoting or suppressing allergic diseases (Akdis, 2006; Wing
and Sakaguchi, 2006). Allergen-specific Treg and Tr1 cells are
thought to control allergy by secreting IL-10 and TGF-b, sup-
pressing IgE production by B cells, and decreasing Th2 cellImmunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc. 771
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Suppression of Allergic Responses by Regulatory T CellsFigure 1. In Vivo Colocalization of Foxp3+
Treg Cells and Mast Cells and In Vitro
Impairment of IgE-Mediated Degranulation
of BMMCs by Treg Cells
(A) Inguinal lymph node sections were stained with
mouse anti-rat-Fc3RIb (red) and rat anti-mouse-
Foxp3 (brown). Arrows indicate cell-cell contact.
Original magnification was 4003.
(B) BMMCs sensitized with IgE anti-DNP (IgE) and
challenged with Ag (IgE-Ag) in the absence or
presence of equal amounts of CD4+CD25+ Treg
cells (Treg cells), CD4+CD25 T cells (resting
T cells), or a-CD3- plus a-CD28-stimulated
CD4+CD25 effector T cells (Teff cells) were
examined for release of b-hexosaminidase, ex-
pressed as a percentage of the cells’ total media-
tor content. Shown are the means ± SD of four
independent experiments, each performed in
duplicate.
(C) TNF-a and IL-6 concentrations were evaluated
in the supernatants of BMMC-Treg cell cocultures.
Shown are the means ± SD of three independent
experiments.cytokines, thus indirectly inhibiting the effector functions of MCs
and basophils.
In this study, we investigated the possibility that Treg cells
might directly modulate the acute phase of allergic reactions by
affecting the Fc3RI-initiated MC degranulation. This was based
on previous findings demonstrating that MCs can physically in-
teract with T cells (Bhattacharyya et al., 1998) and are essential
intermediaries in Treg cell tolerance (Lu et al., 2006). Our findings
showed that CD4+CD25+Foxp3+ Treg cells were able to dampen
the release of prestored allergic mediators from MCs through an
OX40-OX40L-dependent mechanism. The interaction of Treg
cells with MCs impaired the influx of extracellular Ca2+ after
Fc3RI triggering. This was not a consequence of impaired phos-
pholipase C-g2 (PLC-g2) activation or defective Ca2+ release
from intracellular stores.TheTregcell-mediatedsuppressionwas
accompanied by increased cyclic adenosine monophosphate
(cAMP) in the suppressed MCs, and antagonism of cAMP re-
versed the inhibitory effect of Treg cells on MCs, demonstrating
that cAMP increase in MCs is the likely mechanism for suppres-
sion of Ca2+ influx. Finally, in vivo depletion or inactivation of Treg
cells enhanced the extent of histamine release in a mouse model
of systemic anaphylaxis, a common IgE-mediated type I hyper-
sensitivity reaction involving MC degranulation. These findings
underscore the broad immunosuppressive efficacy of Treg cells
by demonstrating their control on immediate allergic responses.
RESULTS
Treg Cells Impair Fc3RI-Mediated MC Degranulation
MCs are activated in various T cell-mediated inflammatory
processes, reside in physical proximity to T cells, and contribute
to T cell recruitment, activation, and proliferation (Kashiwakura
et al., 2004; Nakae et al., 2006). T cell-derived cytokines and772 Immunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc.adhesion-molecule-dependent contact between effector
T cells (Teff cells) andMCs result in the release of both preformed
granule contents and de novo-synthesized cytokines from the
latter (Inamura et al., 1998). However, it is not known whether
Treg cells can be found in contact with MCs in vivo and whether
they can directly affect the immediate hypersensitivity response
of MCs.
Immunohistochemical analysis of inguinal lymph node of
C57BL/6 mice revealed Fc3RIb+ MCs in close proximity to
Foxp3+ Treg cells, suggesting the possibility of crosstalk be-
tween these two cell types (Figure 1A). Our initial experiments
explored the consequences of different T cell subsets on
Fc3RI-initiated degranulation of bone marrow-derived cultured
MCs (BMMCs) from C57BL/6 mice (Figure 1B). Degranulation
was measured by the release of the MC granule-associated
enzyme b-hexosaminidase. As shown in Figure 1B, Treg cells
significantly inhibited BMMC degranulation, with IgE-antigen
(Ag)-stimulated MCs alone releasing 36% ± 5% of their granule
contents compared with 16% ± 5% for MCs coincubated with
Treg cells (p = 0.003). In contrast, anti-CD3+ anti-CD28-activated
CD4+ T cells (Teff) significantly enhancedMC IgE-Ag-dependent
degranulation (56% ± 6% degranulation; p = 0.005), in agree-
ment with previous findings (Inamura et al., 1998). Treg cells
from BALB/c mice cocultured with syngenic BMMCs showed
a similar ability to inhibit MC degranulation (Figure S1 available
online). The Ag-induced release of TNF-a and IL-6 was not
affected by the presence of Treg cells when compared with
that for BMMCs cultured alone (Figure 1C).
Increasing the Treg cells:MCs ratio or preincubating the two
cell types for up to 30minbeforeAg challengedid not cause a fur-
ther decrease in MC degranulation (data not shown), indicating
that a rapid mechanism for MC inhibition by Treg cells underlies
the observed effect. This also suggested that cell-cell contact
Immunity
Suppression of Allergic Responses by Regulatory T Cellsmight be important because de novo production of cytokines
normally requires a few hours poststimulation. To explore this
possibility,weassayeddegranulationwith a transwell to separate
Treg cells and MCs. Figure 2A shows that the inhibition of Fc3RI-
dependent MC degranulation by Treg cells was abolished when
MCs and Treg cells were separated by the transwell membranes,
thus revealing the requirement for cell-cell contact.
OX40-OX40L Interaction Is Required for Treg
Cell-Mediated Inhibition of MC Degranulation
MCs constitutively express OX40L (encoded by Tnfsf4), which
mediates MC-induced T cell proliferation in vitro (Kashiwakura
et al., 2004; Nakae et al., 2006). OX40 (encoded by Tnfrsf4) is
constitutively expressed on naive and activated Treg cells, and
its signal can modulate Treg cells’ suppression of Teff cells
(Takeda et al., 2004; Valzasina et al., 2005). Thus, we investigated
whether OX40L-OX40 interaction might function to mediate the
inhibitory effect of Treg cells onMC activation. Treg cells isolated
from Tnfrsf4/ mice poorly inhibited MC degranulation, with re-
sponses of IgE-Ag-activated MCs at 36% ± 5% compared with
28%± 4%degranulation in the presence of Tnfrsf4/ Treg cells.
However, this difference was not significant (Figure 2A). This
suggested a dominant mechanism of inhibition mediated by
OX40 on Treg cells, although other interactions or factors might
contribute a minor component of the inhibitory effect on MCs.
Figure 2. The Contact-Dependent Inhibi-
tory Role of Treg Cells onMCDegranulation
Depends on OX40 Expression by Treg Cells
and Requires OX40L on BMMCs
(A) BMMCs sensitized with mouse IgE anti-DNP
(IgE) and challenged with Ag (IgE-Ag) in the
absence or presence of equal amounts of WT or
Tnfrsf4/ CD4+CD25+ Treg cells or separated
by a transwell membrane (Transwell) were then
examined for release of b-hexosaminidase.
(B) Same as (A), but BMMCs were obtained from
WT or Tnfsf4/ mice and cocultured with WT
CD4+CD25+ Treg cells.
(C) IgE-sensitized BMMCs were challenged with
Ag in the absence or presence of membranes
from K562 cells expressing OX40 (K562-OX40) or
empty vector (K562).
(D) IgE-sensitized BMMCs were challenged with
Ag in presence of Treg cells, plus blocking anti-
OX40L (clone MGP34) or isotype control (rat
IgG2c). All the graphs show the means ± SD of
three independent experiments, each performed
in duplicate.
The reverse experiment showed the
importance of OX40L in MCs for Treg
cell-mediated inhibition, given that
BMMCs differentiated from OX40L-defi-
cient mice (Tnfsf4/) were completely
resistant to the Treg cells’ inhibitory effect
(Figure 2B). The presence of OX40 on
wild-type (WT) and its absence on
Tnfrsf4/ Treg cells, as well as the pres-
ence of OX40L on unstimulated or IgE-
Ag-stimulated BMMCs or its absence in
Tnfsf4/ BMMCs, was demonstrated by flow cytometry (Fig-
ures S2 and S3A, respectively). To explore whether the triggering
through OX40-OX40L was required for the inhibitory effect on
MCs, we stimulated BMMCs in the presence of OX40-express-
ing membranes derived from the chronic myelogenous leukemia
K562 cell line or incubated them with Treg cells in the presence
of an OX40L-blocking antibody. OX40-expressing K562 mem-
branes also elicited an inhibitory effect on MC degranulation,
although one that was weaker than that in presence of Treg cells
(Figure 2C). Additionally, when BMMCs were incubated with a
blocking OX40L antibody, the inhibitory effect of Treg cells on
MC degranulation was reversed (Figure 2D). Fc3RI expression
was not altered by OX40L deficiency, nor modulated in BMMCs
in the presence of WT or Tnfrsf4/ Treg cells (Figures S3B and
S3C). No major differences were observed between Tnfrsf4/
and WT Treg cells in expression of other costimulatory mole-
cules (Figure S3D). These experiments demonstrated that
OX40-OX40L interactions between Treg cells and MCs, respec-
tively, appear to be the unique requirement for the dampening of
MC degranulation.
Treg Cells Inhibit Ca2+ Influx in MCs Independently
of PLC-g Activation or Ca2+ Mobilization
To explore the underlying mechanism for the inhibitory effect of
Treg cells onMCdegranulation, we investigated signaling eventsImmunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc. 773
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about the signals generated subsequent to OX40L stimulation,
but it has been published that OX40L engagement results in
the rapid translocation of the Ca2+-dependent protein kinase C
(PKC)-b to the membrane of human airway smooth muscle cells
(Burgess et al., 2004). Ca2+ mobilization and PKC-b activation
are known to be absolutely essential for MCdegranulation (Blank
and Rivera, 2004). Ca2+ mobilization is initiated by the phosphor-
ylation of PLC-g after Fc3RI engagement, which leads to the
hydrolysis of phosphatidylinositol-4,5-biphosphate to inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 causes
mobilization of intracellular Ca2+ ([Ca2+]i) from endoplasmic retic-
ular stores, whereas DAG and Ca2+ act in concert to promote
activation of Ca2+-dependent PKCs, like PKC-b. The emptying
Figure 3. Treg Cells Do Not Affect Fc3RI-
Dependent PLC-g Phosphorylation
WT or Tnfsf4/ sensitized BMMCs were stimu-
lated with Ag in the presence of WT or Tnfrsf4/
Treg cells for the indicated times. Cells were
immediately fixed and stained for c-kit and phos-
phorylated PLC-g2. From c-kit+-gated BMMCs
(A), histogram overlays of phosphorylated PLC-
g2 at different time points were obtained from
WT (upper panels) or Tnfsf4/ (lower panels)
BMMCs challenged in absence of Treg cells (B).
Dot plot overlay of basal phosphorylated PLC-g2
at 0 min (left, gray) and after 10 min (right, violet)
is shown in (C). Histogram overlays of phosphory-
lated PLC-g2 from WT (upper panels) or Tnfsf4/
(lower panels) BMMCs challenged in the presence
of Treg cells are shown in (D). Results shown are
representative of three independent experiments.
Kinetics of PLC-g2 phosphorylation at different
conditions are shown in (E) and are the mean ±
SD of three independent experiments.
of internal stores triggers Ca2+ influx
from external sources, a step required
for MC degranulation (Gilfillan and
Tkaczyk, 2006).
We first explored whether a defect in
the activation of PLC-g2 (as measured
by phosphorylation at the Y759 site,
known to be required for lipase activity)
was present. The PLC-g2 isoform was
chosen for its essential role in MC
degranulation (Wen et al., 2002). Rapid
tyrosine phosphorylation of the PLC-g2
isoform was detected upon Fc3RI
engagement in both WT and Tnfsf4/
BMMCs (Figures 3A, 3B, and 3C). Al-
though a trend toward a slightly more
transient phosphorylation was observed
in Tnfsf4/ BMMCs, this was not signifi-
cant. Moreover, the presence of WT or
Tnfrsf4/ Treg cells did not significantly
alter the phosphorylation of PLC-g2 in ei-
ther WT or Tnfsf4/ BMMCs (Figures 3D
and 3E).
Recent studies demonstrated that in MCs, extracellular Ca2+
influx can be regulated independently of PLC-g, for example,
through the activity of sphingosine kinase 2 (Olivera et al.,
2007). Thus, investigating the effects of WT and OX40-deficient
Treg cells on the Ca2+ response of MCs was warranted. Interest-
ingly, we observed that Fc3RI-dependent Ca2+ mobilization in
MCs was impaired in the presence of WT Treg cells, but not
OX40-deficient Treg cells (Figure 4A). Given that PLC-g2 activa-
tionwas largely unaffected, this suggested that the effect onCa2+
mobilization was probably independent from the emptying of
intracellular stores. Indeed, the depletion of extracellular Ca2+
showed that MCs had a relatively normal mobilization of Ca2+
from intracellular stores in the presence of Treg cells. However,
restoration of Ca2+ in the extracellular medium revealed a774 Immunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc.
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inability of these MCs to flux Ca2+ across the plasma membrane
in the absence or presence of Treg cells was consistent with their
normal or decreasedMCdegranulation, respectively (Figures 4C
and 4D). Thus, when activated in the presence of WT Treg cells,
but notOX40null Treg cells,MCs showed reducedCa2+ influx, in-
dependently of PLC-g2 or Ca2+ release from intracellular stores.
cAMP Is Involved in Treg Cell-Mediated Suppression
of BMMC Activation
Our data indicated that Treg cells directly inhibited MC degranu-
lation by cell-cell contact through the interaction of OX40 on Treg
cells with OX40L on MCs, resulting in the suppression of Ca2+
influx inMCs upon Fc3RI stimulation. However, how these events
are linked remained tobeexplored. Tregcells havebeen reported
Figure 4. Reduced Fc3RI-Dependent Ca2+ Influx after BMMC-Treg
Cell Engagement, but Not Intracellular Ca2+ Mobilization
(A) BMMCs loaded with FURA-2AM were stimulated via Fc3RI in the absence
(BMMCs, black line) or presence of CD4+CD25 T cells (resting T cells, green
line), WT CD4+CD25+ Treg cells (red line), or Tnfrsf4/ CD4+CD25+ Treg cells
(blue line), and fluorescence emission was monitored.
(B) FURA-2AM-loaded BMMCs were stimulated via Fc3RI and cocultured with
WT CD4+CD25+ Treg cells (red line) in the absence of extracellular Ca2+. 400 s
after Ag stimulation, 2 mM Ca2+ was added to the medium, and fluorescence
emission was monitored.
(C and D) At the end of each experiment, 14 min after Ag addition, the percent-
age of b-hexosaminidase release from each individual sample was measured.
Results shown are the mean ± SD of one representative experiment from three
independent experiments.to block Teff cell functions by producing cAMP. Thus, one possi-
bility was that Treg cell-mediated suppression of MCs might
occur through Treg cells’ production of cAMP, which could lead
to decreased Ca2+ influx and suppression of degranulation in
BMMCs, as recently shown (Hua et al., 2007). We first confirmed
this effect by treating MCs with forskolin, which raises the intra-
cellular cAMP concentration, and found that this treatment
caused inhibition of MC degranulation (Figure S4) and induced
a 1.5-fold increase in cAMP concentrations in BMMCs (Fig-
ure 5A). When IgE-Ag-activated BMMCs were incubated in the
presence of Treg cells, cAMP concentrations in sorted BMMCs
increased by approximately 3-fold (Figure 5A; p = 0.005). No in-
crease in cAMP was observed when BMMCs were cocultured
with Tnfrsf4/ Treg cells or when Tnfsf4/BMMCswere cocul-
turedwith Treg cells (Figure 5A). No differences were found in the
intracellular concentrations of cAMP in WT and Tnfrsf4/ Treg
cells alone or coincubated with BMMCs (Figure 5B). Therefore,
these findings showed that constitutive OX40-OX40L interaction
between Treg cells and MCs resulted in significant increase of
cAMP only in the MCs. To address the possibility that OX40-
OX40L interactions might enhance gap-junction formation,
resulting in cAMP transfer from Treg cells to MCs as previously
described for Treg cell-Teff cell interactions (Bopp et al., 2007),
we first incubated BMMCs with OX40-expressing membranes
from the K562 cell line and found that cAMP increased in MCs,
albeit at lower amounts than with intact cells (Figure 5C). This
was consistent with the more modest inhibitory effect of such
OX40-expressing membranes on MC degranulation (Figure 2C),
which likely reflects a less extensive engagement of OX40L by
K562 OX40-expressing membranes relative to intact Treg cells.
To fully exclude the passage of cAMP from Treg cells to MCs,
we measured the transfer of calcein, a dye that diffuses only via
gap junction (Fonseca et al., 2006), and found no transfer (Fig-
ure S5). These data suggest that the rise of cAMP in MCs is likely
to result from intracellular signals induced by Treg cells to MCs
through OX40L engagement. To determine whether the reversal
of cAMP increase would cause reversal of the inhibitory effects,
we pretreated MCs with the antagonist Rp-cAMP (shown to
block cAMP-dependent PKA activity) and then tested MC
degranulation andCa2+mobilization in thepresence of Treg cells.
Treatment with Rp-cAMP did not alter either cell viability or the
threshold of MC activation (data not shown). Rp-cAMP-treated
BMMCs were resistant to the inhibitory effects of Treg cells
upon Fc3RI stimulation, showing a degranulation response iden-
tical to that of Fc3RI-stimulated MCs in the absence of Treg cells
(Figure 5D).Moreover, in presence of theRp-cAMP, the uptake of
extracellular Ca2+ was unaffected by the presence of Treg cells
(Figure 5E). Thus, cAMP increment within MCs is the mechanism
responsible for Treg cells’ inhibition of MC degranulation.
Treg Cells Control MCs’ Ability to Release Histamine
In Vivo through Constitutive OX40 Expression
To evaluate the role of Treg cells on the in vivo function of MCs,
we employed an Fc3RI-mediated acute-systemic-anaphylaxis
model. This model depends on MCs, given that the observed
increase in circulating histamine upon IgE-Ag stimulation is min-
imal in MC-deficient, c-kit-deficient mice (W/Wv) and absent in
MC-deficient, stem-cell-factor-deficient mice (Sl/Sld). We first
explored the effect of OX40 deficiency on the anaphylacticImmunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc. 775
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Inducing the Increase of Intracellular
cAMP in MCs
Sensitized WT and Tnfsf4/ BMMCs were CFSE
labeled and Ag stimulated alone or with WT or
Tnfrsf4/ Treg cells. BMMCs and Treg cells
were separated with FACS-based cell sorting,
and cytosolic cAMP concentrations were mea-
sured with a cAMP-specific enzyme-linked immu-
nosorbent assay (ELISA). As a positive control,
sensitized BMMCs were incubated with forskolin
and challenged with Ag.
(A) BMMCs’ baseline [cAMP] was 10 pmoles/1 3
105 BMMCs. Results are expressed as fold
induction over BMMCs alone.
(B) Treg cells’ baseline [cAMP] was 50 pmoles/13
105 Treg cells. Results are expressed as fold
induction over Treg cells alone.
(C) Sensitized BMMCswere activatedwith Ag plus
K562 or K562-OX40membranes. The means ± SD
of three independent experiments are shown.
(D) Anti-DNP-IgE-preloaded BMMCs were prein-
cubated for 30 min with 1 mM of the specific
cAMP antagonist Rp-cAMP. Cells were washed
and activated with Ag separately (BMMCs) or in
coculture with CD4+CD25+ Treg cells (BMMCs +
Treg cells). After 30 min, samples were exam-
ined for release of b-hexosaminidase as de-
scribed. Shown are the means ± SD of three
independent experiments, each performed in
duplicate.
(E) IgE-sensitized BMMCs were preincubated
for 30 min with 1 mM of the specific cAMP antag-
onist Rp-cAMP, and Ca2+ mobilization was
assessed as described in Figure 4B. Results
shown are representative of three independent
experiments.response by use of C57BL/6 Tnfrsf4/mice and the appropriate
WT controls. As shown in Figure 6, Tnfrsf4/ mice had signifi-
cantly (p = 0.001) higher amounts of circulating histamine after
challenge than did WT mice. The increase in circulating hista-
mine concentrations ranged from 20%–35% of that seen in WT
mice, with a mean increase of approximately 25%. To directly
assess the importance of Treg cells, we used the approach of se-
lectively depleting or inactivating these cells. C57BL/6 WT mice
were treated with a CD25 antibody (PC61 Ab) 7 and 8 days prior
to IgE sensitization for depletion of Treg cells. PC61 Ab was
demonstrated to diminish Treg cell numbers but also decrease
CD25 expression (Kohm et al., 2006; Simon et al., 2007). Thus,
we measured both CD25 and Foxp3 expression in PC61-treated
mice. We observed that more than 50% of Foxp3+ T cells were
decreased in both circulating blood cells and lymph nodes,
and we also observed a more marked decrease (greater than
80% in the lymph nodes) in CD25 expression by Foxp3+ T cells
(Figure S6). Upon systemic anaphylactic challenge of Treg cell-
depleted mice, circulating histamine concentrations mirrored
those of OX40-deficient mice, showing a significant (p < 0.005)776 Immunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc.increase relative to those of WT controls (Figure 6A). No signifi-
cant difference in Fc3RI expression was detected in peritoneal
MCs (CD45+ c-kit+) from non-IgE-sensitized mice, thus exclud-
ing the possibility that CD25 antibody treatment or OX40 defi-
ciency might cause increased Fc3RI expression and contribute
to the observed in vivo effects (Figure 6B). Because differences
in circulating IgE concentrations could affect the in vivo response
of MCs by saturating Fc3RI and increasing its expression (Yama-
shita et al., 2007), we measured serum IgE concentrations
among Tnfrsf4/ mice, PC61-treated mice, and WT controls
and found them to be similar among all mice used in these exper-
iments (data not shown). To more definitely show the role of
OX40 expressed by Treg cells in controlling MC degranulation,
we measured anaphylactic response in Treg cell-depleted thy-
mectomized mice that had been left unreconstituted or reconsti-
tutedwithWT or OX40-deficient Treg cells (Figure 6C). Strikingly,
exogenous WT cells, but not Tnfrsf4/ Treg cells, were able to
revert in vivo the increased MC degranulation occurring in Treg
cell-depleted hosts, thus proving the essential role of OX40 in
mediating MC suppression by Treg cells.
Immunity
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cells in suppressing Fc3RI-induced MC degranulation in vivo in
an OX40-dependent manner.
DISCUSSION
In recent years, MCs have been recognized to influence or be
influenced by dendritic cells, T cells, and B cells, thus functioning
as regulatory and/or effector cells (Sayed and Brown, 2007).
However, little is known about this communication and the
involvement of direct cell-cell contact. Because we found Treg
cells and MCs in close proximity in vivo, we investigated the
consequence of their interaction on MC effector responses.
Here, we reported that Treg cells (but not other T cell popula-
tions) can inhibit MC degranulation through cell-cell contact.
Specifically, we found that the interaction of OX40-expressing
Treg cells with OX40L-expressing MCs inhibited the extent of
MC degranulation in vitro and of the immediate hypersensitivity
response in vivo. These findings established a previously unrec-
ognized Treg cell-dependent regulation of MCs, the alteration of
which might result in pathology. The functional presence of
Figure 6. Treg Cells In Vivo Reduce via
OX40 the Systemic Release of Histamine
by MCs
(A) Plasma histamine levels were measured
1.5 min after challenge with PBS (mock) or DNP-
HSA (DNP) in anti-CD25-treated mice, Tnfrsf4/
mice, and controlWT littermates that were presen-
sitized with IgE anti-DNP (n = 8 in each group).
Results shown are pooled from two independent
experiments.
(B) CD45+ c-kit+ peritoneal MCs (PMC, left panel)
from unsensitized mice in each experimental
group were stained for Fc3RI (black lines) or iso-
type control (shaded areas). Mean fluorescence
intensity (MFI) is indicated.
(C) Thymectomized (tmx) and anti-CD25-treated
mice were left unreconstituted or received i.v.
3 weeks after 1.5 3 106 Treg cells obtained from
WT or Tnfrsf4/ donors. After 3 days, passive
systemic anaphylaxis was induced, and plasma
histamine was measured as in (A).
OX40L on both human and mouse MCs
(Kashiwakura et al., 2004; Nakae et al.,
2006) suggests that this regulatory mech-
anism is conserved across species.
Tnfrsf4/ (OX40-deficient) mice do not
have a higher incidence of spontaneous
allergic disease, but rather, they show
impaired development of allergic inflam-
mation due to the requirement for OX40
in the development of Th2 cells (Jember
et al., 2001; Salek-Ardakani et al., 2003).
Bypassing this requirement for Th2 cell
polarization and directly challenging the
effector arm (MCs) of an allergic response,
we revealed a role for Treg cell-expressed
OX40 as a negative regulator dampening
the immediate hypersensitivity caused by MCs. Whether this
control of MC function extends beyond allergic responses is un-
clear. However, given the increasing evidence of a role for MCs
in autoimmune diseases (Christy and Brown, 2007) and the dem-
onstration that some organ-specific autoimmune disease can be
mediated through MC-derived histamine and serotonin (Binstadt
et al., 2006), the Treg cell-MC interplay herein described is poten-
tially relevant to the development of autoimmunity. Notably,
mutations in the X chromosome-encoded Foxp3 gene (leading
to Treg cell loss) were identified as the cause of the early-onset
fatal autoimmune disorder observed in patients with immune
dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX)
syndrome and in scurfy mutant mice. Interestingly, in both
humans and mice, this immune dysregulation is associated with
increased asthma and allergy (Patel, 2001), thus arguing for the
need of Treg cells in controlling allergic responses.
Tnfsf4/ (OX40L-deficient) mice also display marked reduc-
tion of Th2 cell responses (Arestides et al., 2002; Hoshino et al.,
2003). However, like in Tnfrsf4/ mice, these effects can all be
associated with the presence of OX40L, on activated APC, trig-
gering Th2 cell polarization (Linton et al., 2003). Thus, althoughImmunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc. 777
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study showed that it also controlled the allergic response.
Consistent with this view is the finding that induction of aller-
gen-specific tolerant T cells caused a decrease in circulating
histamine after allergen challenge in a mouse model of bronchial
asthma (Treter and Luqman, 2000). This suppressive effect could
not be entirely explained by reduced amounts of allergen-
specific IgE, suggesting that tolerant T cells might act in another
manner to modulate the Fc3RI-dependent histamine release.
Treg cell-mediated control of degranulation transcends the
MCs, given that granule exocytosis from cytotoxic T lympho-
cytes is inhibited in the presence of Treg cells through their phys-
ical interaction (Mempel et al., 2006). Notably, the inhibitory
effect of Treg cells on MC degranulation, although considerable,
was not complete and did not affect cytokine production. This
selective inhibition of MC responses may underlie the complex
relationship between Treg cells and MCs.
Considerable emphasis has recently beenplaced on the role of
MCs as effectors in Treg cell tolerance. Unlike what is described
here, soluble factors like Treg cell-derived IL-9 play a key role in
mediating MC recruitment, and MC-secreted IL-10 and/or
TGF-b may be involved in mediating the suppressive effects
(Hawrylowicz and O’Garra, 2005; Lu et al., 2006). However, it re-
mains to be determined whether MC degranulation is impaired
when these cells act as effectors in Treg cell-mediated tolerance.
Although it is well known that MCs can produce cytokines in the
absence of degranulation (Theoharides et al., 2007), less is
known about the impairment of MC degranulation when cytokine
production is unaffected, but this type of effect is likely to require
the selective dampening of signals.
The mechanism by which OX40-OX40L interaction drives
inhibition of MC degranulation involves increased cAMP content
within MCs. MC degranulation requires Ca2+ influx through
store-operated Ca2+ channels that are sensitive to membrane
potentials, which can be influenced by the ion balance across
the plasma membrane. cAMP is known to alter the membrane
potential, as observed in rat peritoneal MCs (Bradding, 2005;
Penner et al., 1988). High cAMP concentrations within MCs were
shown to cause decreased Ca2+ influx and inhibit degranulation
(Hua et al., 2007). This inhibition is likely to result from the abso-
lute requirement of the MC secretory granule fusion machinery
for Ca2+ influx, given that the release of Ca2+ from intracellular
stores alone is not sufficient to properly activate secretory fusion
proteins (Blank and Rivera, 2004). Importantly, we found that
drug-mediated antagonism of cAMP in OX40L-stimulated MCs
reversed the decrease in Ca2+ influx and the inhibition of
degranulation.
The inhibitory effect of cAMP also transcends the MCs, given
that Treg cell suppression on Teff cells is wielded through cAMP
transfer via gap junctions (Bopp et al., 2007). MCs express
connexins and can form hexameric hemichannels, which do
align in neighboring cells, forming gap junctions during cell con-
tact (Vliagoftis et al., 1999). Thus, cAMP transfer was plausible
between Treg cells and MCs. However, after the Treg cell-MC
coincubation, cAMP increase was detected ı`n MCs without the
requirement of an intact OX40+ cell, given that OX40-expressing
K562 cell membranes could also elicit cAMP production in MCs.
Moreover, no decrease in intracellular cAMP concentration was
apparent in Treg cells after coincubation, excluding the translo-778 Immunity 29, 771–781, November 14, 2008 ª2008 Elsevier Inc.cation of cAMP from Treg cells to MCs. Finally, we failed to ob-
serve the transfer of calcein from Treg cells to MCs, suggesting
that the increased cAMP elicited by OX40-OX40L interactions
must be a result of OX40L signal inMCs triggering cAMPproduc-
tion. This argument is well supported by use of the antagonist
Rp-cAMP, which reversed the effects of increased cAMP,
namely inhibition of Ca2+ influx and of MC degranulation.
Direct antibody triggering of OX40L on MCs was not possible
in this study because the available antibodies are crossreactive
with the FcgR on MCs. Thus, signaling and function of OX40L
onMCs remain to be elucidated.More is known about the effects
of OX40 triggering on Treg cells. Virtually all Treg cells constitu-
tively express OX40 at the naive stage, and OX40 engagement
abolishes Treg cell suppression in vitro and in vivo (Takeda
et al., 2004; Valzasina et al., 2005). This would suggest that
OX40 engagement by OX40L-expressing MCs might reverse
Treg cells’ suppressive function, even though the complex
consequences of this effect require further investigation. There
is mounting evidence that deficiency in Treg cell number or
function contributes to common allergic diseases and asthma.
Here, we find that the decrease in Treg cells and/or their loss
of function increases the responsiveness of MCs in vivo. Gluco-
corticoids, the most effective treatment for allergy, as well as the
agonist of histamine receptor 4, induce the activation of Treg
cells (Karagiannidis et al., 2004; Morgan et al., 2007). These
findings suggest that the contribution of Treg cells toward the
reduction of allergy could be mediated not only by inhibition of
T cell-driven inflammation, but also by direct regulation of the
release of preformed proinflammatorymediators byMCs. There-
fore, induction and expansion of Treg cells could be a useful
strategy in controlling allergen-mediated hypersensitivity.
EXPERIMENTAL PROCEDURES
Mice, Treatments, and Reagents
C57BL/6 and BALB/c mice were purchased from Harlan. C57BL/6 OX40-
deficient mice (Tnfrsf4/) (Pippig et al., 1999) were from the University of
California at San Francisco. Bone marrow from C57BL/6 OX40L-deficient
mice (Tnfsf4/) was kindly provided by A.H. Sharpe, Harvard Medical School,
Boston, USA.Miceweremaintained under pathogen-free conditions at the an-
imal facility of Fondazione IRCCS Istituto Nazionale dei Tumori Milano. Animal
experimentswere authorized by the Institute Ethical Committee and performed
in accordance with institutional guidelines and national law (DL116/92). For
in vivo experiments, mice intraperitoneally received 0.5 mg/0.2 ml of anti-
CD25 (clone PC61, rat IgG1, ATCC, LGC) 7 days and 8 days prior to the
systemic anaphylaxis induction. Anesthetized mice were thymectomized by
suction method 4 days before PC61 injection and 3 weeks before i.v. transfer
of 1.53 106 Treg cells. After 3 days, systemic anaphylaxiswas induced.Murine
DNP-specific IgE was produced as described (Liu et al., 1980). DNP-human
serumalbumin (DNP36-HSA, Ag) and forskolin were fromSigma-Aldrich. Aden-
osine 30,50-cyclic monophosphorothioate, Rp-isomer, triethylammonium salt
(Rp-cAMP) was from Calbiochem (Merck Biosciences).
Lymph Node Immunolabeling
For double immunohistochemical staining, 4 mm-thick sections were cut from
formalin-fixed, paraffin-embedded inguinal lymph node samples from 8-week-
old C57BL/6. Slides were preincubated with protein block (Novocastra), incu-
bated with mouse anti-rat-Fc3R (clone IRK) (Rivera et al., 1988) and then with
biotinilated swine anti-mouse Ab and streptavidin-conjugated alkaline phos-
phatase (LSAB+kit, Dako), and labeledwith the fast redchromogenic substrate
(Dako). Sections were incubated with the primary rat anti-mouse Foxp3 (clone
FJK-16s, eBioscience) and secondary horseradish peroxidase (HRP)-conju-
gated anti-rat Ig and labeled with hydrogen peroxide-diaminobenzidine
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DM2000 optical microscope, and microphotographs were collected with a Le-
ica DFC320 digital camera (Leica Microsystems).
Purification of CD4+CD25+ and CD4+CD25 Subsets
CD4+CD25+ cells were purified with the CD25+ T cell isolation kit (Miltenyi
Biotec) according to the manufacturer’s instructions. Flow cytometry showed
that the separated fractions weremore than 90%Foxp3+ (Figure S2). For some
experiments, CD4+CD25 T cells were stimulated for 72 hr with 1 mg/ml of
plate-coated anti-CD3 plus 2.5 mg/ml of soluble anti-CD28 (both from
eBioscience).
Bone Marrow-Derived Mast Cell Differentiation,
Activation, and Fc3RI Expression
BMMCs were obtained by in vitro differentiation of bone marrow cells taken
from mouse femur as described (Frossi et al., 2007). After 5 weeks, BMMCs
were monitored for Fc3RI expression by flow cytometry. Purity was usually
more than 97%. BMMCs were obtained from three to four mice, and all exper-
iments were performed with at least three individual BMMC cultures. Before
experiments, 1 3 106 BMMCs per ml were sensitized in medium without
IL-3 for 4 hr with 1 mg/ml of DNP-specific IgE and challenged with DNP-HSA
in Tyrode’s buffer (10 mM HEPES buffer [pH 7.4], 130 mM NaCl, 5 mM KCl,
1.4 mM CaCl2, 1mM MgCl2, 5.6 mM glucose, and 0.1% BSA). For measure-
ment of Fc3RI expression ex vivo, MCs were enriched from peritoneal lavage
by 70% Percoll Gradient (GE Healthcare) and stained with APC anti-CD45
(clone 104), FITC anti-c-kit (clone 2B8), and PE anti- Fc3RI (clone MAR-1), all
from eBioscience.
b-hexosaminidase- and Cytokine-Release Assay
and PLC-g2 Phosphorilation
IgE-presensitized BMMCs were challenged in Tyrode’s buffer with Ag
(100 ng/ml) for 30 min in the presence or absence of equal amounts of the in-
dicated cell types. In some experiments, BMMCs and T cells were separated
by a 3.0 mm transwell membrane (Corning Life Sciences). In some experi-
ments, presensitized BMMCs were incubated for 30 min with 10 mg/ml block-
ing anti-OX40L (clone MGP34) (Murata et al., 2000) or isotype control (rat
IgG2c) before Ag challenge in presence of CD4+CD25+ Treg cells. Samples
were placed on ice and immediately centrifuged to pellet cells. The enzymatic
activities of b-hexosaminidase in supernatants and in the cell pellets, after
solubilizing with 0.5% Triton X-100 in Tyrode’s buffer, were measured with
p-nitrophenyl N-acetyl-b-D-glucosaminide in 0.1 M sodium citrate (pH 4.5)
for 60 min at 37C. The reaction was stopped by addition of 0.2 M glycine
(pH 10.7). The release of the product 4-p-nitrophenol was detected by absor-
bance at 405 nm. The extent of degranulation was calculated as the percent-
age of 4-p-nitrophenol absorbance in the supernatants over the sum of absor-
bance in the supernatants and in cell pellets solubilized in detergent. For
cytokine analysis, IgE-sensitized BMMCs and Treg cells were cultured alone
or together for 16 hr in presence of 100 ng/ml Ag. Concentrations of
TNF-a and IL-6 were determined in supernatants with Mouse Inflammation
Kit (BD Biosciences). For assessment of PLC-g2 phosphorilation, BMMCs
were Ag stimulated in the presence of Treg cells and fixed after the indicated
time, then immediately stained with a PE-conjugated anti-PLC-g2 (pY759) (BD
Biosciences) and FITC anti-c-kit (clone 2B8, eBioscience). Flow-cytometry
data were acquired on a FACSCalibur (Becton Dickinson) and analyzed with
FlowJo software (version 8.5.2; Treestar).
Expression of Mouse OX40 by K562 Cells
and Preparation of Membranes
Human chronicmyelogenous leukemia K562 cells were stably transfected with
empty pCDNA3 plasmid or pCDNA3 expressing murine OX40 molecule
(OX40Dir 50GCGAATTCAGAAAGCAGACAAGG30; OX40Rev 50CACTCGA
GTACTAATGCTCAGAT 30). OX40-positive K562 cell clones were identified
by flow cytometry with anti-mouse OX40 (OX86, BD Biosciences). Membranes
from K562 and K562-OX40 cell clones were prepared as previously described
(Merluzzi et al., 2008) and resuspended at a final concentration of 53 107 cell
equivalents per ml on the basis of the starting cell numbers. Membranes
were added to IgE-sensitized BMMCs at dilution of 1:125 v/v together with
the Ag.Intracellular Ca2+ Determination
For Ca2+ measurements, 1 3 106 IgE-sensitized BMMCs were loaded with
3 mM FURA-2AM (Molecular Probes) in RPMI 2% fetal bovine serum for
45 min at 37C. Cells were washed in Tyrode’s-BSA buffer (Saitoh et al.,
2000), incubated in the presence of equal amounts of the indicated cell types,
and challenged with Ag (20 ng/ml). All fluorescence measurements (excitation
and emission wavelengths, 340/380 and 505 nm, respectively) were per-
formed in a Perkin-Elmer LS-50B spectrofluorimeter (Perkin-Elmer) equipped
with a thermostatically controlled cuvette holder and magnetic stirring. During
the experiment, temperature was kept at 37C. The changes in [Ca2+]i are
expressed as a ratio of the light emitted at 505 nm upon excitation at the
two wavelengths, 340 and 380 nm (F340/F380).
FACS-Based Cell Sort and cAMP ELISA
For evaluation of the intracellular levels of cAMP, presensitized BMMCs were
labeled for 15 min with 5 mM carboxyfluorescein diacetate, succinimidyl ester
(CFDA-SE; CFSE) (Molecular Probes, Invitrogen) and Ag challenged in pres-
ence of Treg cells. After coculture, CFSE-labeled BMMCs and CD25PE-
labeled Treg cells were isolated with a MoFlo cell sorter (Dako). The purity of
the sorted populations was >99%. As positive control, sensitized BMMCs
were incubated with 25 mM forskolin for 1 hr before Ag stimulation. Cells
were washed twice in PBS and lysed in 0.1 M HCl/0.1% Triton X-100
(107 cells/ml). cAMP levels were measured with Correlate EIA Direct cAMP
assay (Assay Design).
Systemic Anaphylaxis
Micewere sensitized with 3 mg of mouse DNP-specific IgE by tail vein injection.
24 hr later, mice were challenged i.v. with 0.5 mg of Ag or vehicle (PBS). After
1.5 min, mice were euthanized with CO2, and blood was withdrawn by cardiac
puncture. Plasma histamine concentration was determined by ELISA
according to the producer’s instruction (DRG Instruments).
Statistical Analysis
Results are expressed as the means ± SD. Data were analyzed with a
nonpaired Student’s t test (Prism software, GraphPad Software).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six
figures and can be found with this article online at http://www.immunity.com/
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